Find uplifting stories about heroes, innovations, and solutions
8569 results for "pancreatitis prevention"
An experimental drug safely activated immune responses against pancreatic cancer in 90% of high-risk patients, offering hope for preventing one of the deadliest cancers. After two years, none of the participants developed cancer.
People living with dangerously high triglycerides now have the first treatment proven to prevent life-threatening pancreatitis attacks. The newly approved medication reduced these devastating events by up to 91% in clinical trials.
Scientists at Johns Hopkins developed a vaccine that may prevent pancreatic cancer before it starts, triggering lasting immune responses in 90% of high-risk patients. None of the 20 participants developed cancer during the study, and some saw their precancerous cysts shrink or disappear.
Yale scientists discovered that omega-3 fats from fish oil slowed pancreatic cancer by 50% in mice, while olive oil's main fat unexpectedly sped up tumors. The breakthrough suggests prevention may hinge on choosing the right fats, not just eating less.
A new vaccine prevented pancreatic cancer from developing in 20 high-risk patients, with 90% showing lasting immune responses. For the first time, researchers have found a way to intercept one of the deadliest cancers before it starts.
Researchers in Spain have eliminated pancreatic tumors in mice using a groundbreaking triple-drug combination. The approach tackles one of the deadliest cancers by preventing treatment resistance.
A groundbreaking study analyzing 185 countries reveals that nearly 40% of cancer cases worldwide could be prevented through lifestyle changes. The findings offer hope that millions of future diagnoses can be avoided through simple choices.
Four out of every ten cancer cases can be prevented with knowledge and technology we already have, according to the World Health Organization. Cancer researcher Dr. Pinar Uysal Onganer says the key is working together on education and early screening.
A massive global study spanning 185 countries reveals that over a third of cancer cases can be prevented through lifestyle changes. The findings arrive as scientists celebrate a "golden age" of cancer treatment breakthroughs.
A groundbreaking UK study reveals that stopping pre-diabetes through simple lifestyle changes could slash healthcare's carbon footprint by two-thirds while adding six years to people's lives. The findings show that preventing and managing diabetes properly isn't just good for patients—it's essential for reaching climate goals.
A major global study reveals that 38% of cancer cases worldwide could be prevented through lifestyle changes and public health action. The research analyzed 36 cancer types across 185 countries and identified clear, proven ways to reduce risk.
University of Pennsylvania researchers eliminated precancerous pancreatic cells in mice before they became tumors, nearly doubling survival time. It's the first proof that medical intervention can stop pancreatic cancer at its earliest stage.
Over 6,000 people in Gauteng, South Africa received a groundbreaking twice-yearly HIV prevention injection in its first month, crushing the province's rollout goal. The success brings the nation closer to ending AIDS as a public health threat by 2030.
Scientists in Spain eliminated pancreatic tumors in mice using a triple-drug therapy, with no cancer returning over 200 days. The breakthrough targets the deadliest form of pancreatic cancer and could reshape treatment if human trials succeed.
A groundbreaking UN study reveals that nearly four in 10 cancer cases worldwide could be prevented through simple lifestyle changes and public health measures. The findings offer concrete hope as researchers identify 30 preventable causes that governments and individuals can address today.
Uganda is expanding access to a groundbreaking HIV prevention injection that only needs to be taken twice a year, offering nearly 100% protection. The innovation could transform HIV prevention for thousands who struggle with daily medication.
After discovering PrEP herself, Brenda Odera now volunteers in Kisumu, Kenya, helping vulnerable young women access HIV prevention medication. Her grassroots work shows how local advocates are making prevention tools available to those who need them most.
A newly approved pill nearly doubles survival time for patients with advanced pancreatic cancer, offering real hope for one of the deadliest cancer types. The breakthrough targets a protein that drives tumor growth in 95% of pancreatic cancer cases.
A new daily pill has earned FDA approval after clinical trials showed it doubled survival time for pancreatic cancer patients when combined with chemotherapy. The drug blocks a mutated protein that drives tumor growth in most pancreatic cancer cases.
A breakthrough drug targeting previously "undruggable" KRAS mutations has approximately doubled survival time for metastatic pancreatic cancer patients compared to chemotherapy. The development marks a historic shift for a disease that affects over 90% of pancreatic cancer cases. --- ##
Showing 20 of 8569